Wei Lai Cheng
Directeur/Membre du Conseil chez Wuhan Grand Hoyo Co., Ltd.
Provenance du réseau au premier degré de Wei Lai Cheng
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Wuhan Grand Hoyo Co., Ltd.
 Wuhan Grand Hoyo Co., Ltd. Chemicals: Major DiversifiedProcess Industries Wuhan Grand Hoyo Co., Ltd. engages in the research, development, and manufacture of the amino acids and their derivatives. Its business scope includes pharmaceutical production; production and sale of food additives; production and sale of feed and feed additives; technology and product development, research, and technical services of bioengineering, new materials, and electronic information; and manufacture and sales of developed product. The company was founded on April 13m 2000 and is headquartered in Wuhan, China.Its products includes Active Pharmaceutical Ingredient (APIs), L-Cysteine and its derivatives, L-Arginine and its derivatives, L-amino acids, Acetyl amino acids, and compound salts of amino acids. The company was founded on April 13m 2000 and is headquartered in Wuhan, China.
7
| Subsidiary | Chemicals: Major Diversified | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Wei Lai Cheng via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Hubei Grand Life Science & Technology Co., Ltd
 Hubei Grand Life Science & Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China. | Pharmaceuticals: Major | Chief Executive Officer | |
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
 Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Grand Pharma (China) Co., Ltd.
 Grand Pharma (China) Co., Ltd. BiotechnologyHealth Technology Part of Grand Pharmaceutical Group Ltd., Grand Pharma (China) Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Wuhan, China. The company was founded in 1939. The CEO is Wei Kun Tang. | Biotechnology | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Chine | 4 |
Sectorielle
| Health Technology | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 11 |
| Chairman | 2 |
| Chief Executive Officer | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Zhi Qiang Qian | 3 |
| Hai Yan Huang | 2 |
| Ju Hua Yuan | 2 |
| Jing Wang | 2 |
| Kai Li | 1 |
| Wen Wen Zhang | 1 |
| Lei Yang | 1 |
- Bourse
- Insiders
- Wei Lai Cheng
- Connexions Sociétés
